Literature DB >> 25656574

PSMB4 promotes multiple myeloma cell growth by activating NF-κB-miR-21 signaling.

Peihao Zheng1, Honggang Guo1, Guangchao Li2, Siqi Han3, Fei Luo4, Yi Liu5.   

Abstract

Proteasomal subunit PSMB4, was recently identified as potential cancer driver genes in several tumors. However, the regulatory mechanism of PSMB4 on carcinogenesis process remains unclear. In this study, we investigated the expression and roles of PSMB4 in multiple myeloma (MM). We found a significant up-regulation of PSMB4 in MM plasma and cell lines. Ectopic overexpression of PSMB4 promoted cell growth and colony forming ability of MM cells, whereas inhibition of PSMB4 led to a decrease of such events. Furthermore, our results demonstrated the up-regulation of miR-21 and a positive correlation between the levels of miR-21 and PSMB4 in MM. Re-expression of miR-21 markedly rescued PSMB4 knockdown-mediated suppression of cell proliferation and clone-formation. Additionally, while enforced expression of PSMB4 profoundly increased NF-κB activity and the level of miR-21, PSMB4 knockdown or NF-κB inhibition suppressed miR-21 expression in MM cells. Taken together, our results demonstrated that PSMB4 regulated MM cell growth in part by activating NF-κB-miR-21 signaling, which may represent promising targets for novel specific therapies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Multiple myeloma; NF-κB pathway; PSMB4; Proteasome; miR-21

Mesh:

Substances:

Year:  2015        PMID: 25656574     DOI: 10.1016/j.bbrc.2015.01.110

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma.

Authors:  Yanxia Jiang; Yajing Luan; Hong Chang; Guoan Chen
Journal:  Oncol Lett       Date:  2018-07-11       Impact factor: 2.967

2.  PSMB5 plays a dual role in cancer development and immunosuppression.

Authors:  Chih-Yang Wang; Chung-Yen Li; Hui-Ping Hsu; Chien-Yu Cho; Meng-Chi Yen; Tzu-Yang Weng; Wei-Ching Chen; Yu-Hsuan Hung; Kuo-Ting Lee; Jui-Hsiang Hung; Yi-Ling Chen; Ming-Derg Lai
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

3.  Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci.

Authors:  Chiara Campo; Miguel Inacio Da Silva Filho; Niels Weinhold; Hartmut Goldschmidt; Kari Hemminki; Maximilian Merz; Asta Försti
Journal:  Neurochem Res       Date:  2016-07-16       Impact factor: 3.996

4.  Scutellarin circumvents chemoresistance, promotes apoptosis, and represses tumor growth by HDAC/miR-34a-mediated down-modulation of Akt/mTOR and NF-κB-orchestrated signaling pathways in multiple myeloma.

Authors:  Lan Li; Yan Zheng; Weihua Zhang; Limin Hou; Ying Gao
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

5.  Upregulation of PSMB4 is Associated with the Necroptosis after Spinal Cord Injury.

Authors:  Chunshuai Wu; Jiajia Chen; Yonghua Liu; Jinlong Zhang; Wensen Ding; Song Wang; Guofeng Bao; Guanhua Xu; Yuyu Sun; Lingling Wang; Limin Chen; Haiyan Gu; Baihong Cui; Zhiming Cui
Journal:  Neurochem Res       Date:  2016-08-11       Impact factor: 3.996

6.  PSMB4 inhibits cardiomyocyte apoptosis via activating NF-κB signaling pathway during myocardial ischemia/reperfusion injury.

Authors:  Chen Yang; Pengyi Yu; Hui Wang; Lei Zhang; Fangfang Yang; Qian He; Bo Jiang; Liang Zheng; Qianyun Wang; Jun Wang; Hui Qiu
Journal:  J Mol Histol       Date:  2021-05-05       Impact factor: 2.611

7.  Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer.

Authors:  Dubravka Škalamera; Mareike Dahmer-Heath; Alexander J Stevenson; Cletus Pinto; Esha T Shah; Sheena M Daignault; Nur Akmarina B M Said; Melissa Davis; Nikolas K Haass; Elizabeth D Williams; Brett G Hollier; Erik W Thompson; Brian Gabrielli; Thomas J Gonda
Journal:  Oncotarget       Date:  2016-09-20

Review 8.  The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma.

Authors:  Bingying Zhu; Shaoqing Ju; Haidan Chu; Xianjuan Shen; Yan Zhang; Xi Luo; Hui Cong
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

9.  Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells.

Authors:  Aikaterini Skorda; Aimilia D Sklirou; Theodore Sakellaropoulos; Despoina D Gianniou; Efstathios Kastritis; Evangelos Terpos; Ourania E Tsitsilonis; Bogdan I Florea; Herman S Overkleeft; Meletios A Dimopoulos; Leonidas G Alexopoulos; Ioannis P Trougakos
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

10.  Acupuncture Decreases NF-κB p65, miR-155, and miR-21 and Increases miR-146a Expression in Chronic Atrophic Gastritis Rats.

Authors:  Jialing Zhang; Kangbai Huang; Guoxin Zhong; Yong Huang; Suhe Li; Shanshan Qu; Jiping Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.